[(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate

C50H85N3O18P2 — CID 156999380

IUPAC[(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate
SMILESCCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H]1COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)[C@@H](CCCCCCC(=O)O1)[C@@H](O)CC(=O)[C@H](/C=C\[C@@H](O)CCCCC)[C@H](O)[C@@H]2O
InChIInChI=1S/C50H85N3O18P2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-23-27-45(57)66-34-38-35-67-72(62,63)71-73(64,65)68-36-43-48(60)47(59)39(30-29-37(54)25-21-6-4-2)41(55)33-42(56)40(26-22-19-20-24-28-46(58)69-38)49(70-43)53-32-31-44(51)52-50(53)61/h12-13,29-32,37-40,42-43,47-49,54,56,59-60H,3-11,14-28,33-36H2,1-2H3,(H,62,63)(H,64,65)(H2,51,52,61)/b13-12-,30-29-/t37-,38+,39-,40-,42-,43+,47-,48+,49+/m0/s1
InChIKeyMAWFXUAGSBZJKG-HFXXXHFHSA-N
MW1078.18 g/mol
LogP7.59
Rot. Bonds24

About [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate

[(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate (PubChem CID 156999380) has the molecular formula C50H85N3O18P2 and a molecular weight of 1078.18 g/mol. Its IUPAC name is [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate.

Molecular Properties

Compound Name[(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate
PubChem CID156999380
Molecular FormulaC50H85N3O18P2
Molecular Weight1078.18 g/mol
Exact Mass1077.53
IUPAC Name[(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate
SMILESCCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H]1COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)[C@@H](CCCCCCC(=O)O1)[C@@H](O)CC(=O)[C@H](/C=C\[C@@H](O)CCCCC)[C@H](O)[C@@H]2O
InChIInChI=1S/C50H85N3O18P2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-23-27-45(57)66-34-38-35-67-72(62,63)71-73(64,65)68-36-43-48(60)47(59)39(30-29-37(54)25-21-6-4-2)41(55)33-42(56)40(26-22-19-20-24-28-46(58)69-38)49(70-43)53-32-31-44(51)52-50(53)61/h12-13,29-32,37-40,42-43,47-49,54,56,59-60H,3-11,14-28,33-36H2,1-2H3,(H,62,63)(H,64,65)(H2,51,52,61)/b13-12-,30-29-/t37-,38+,39-,40-,42-,43+,47-,48+,49+/m0/s1
InChIKeyMAWFXUAGSBZJKG-HFXXXHFHSA-N
XLogP7.59
TPSA323.02 Ų
H-Bond Donors7
H-Bond Acceptors19
Rotatable Bonds24
Heavy Atoms73
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001078.18
LogP ≤ 57.59
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate?
The IUPAC name of [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate (CID 156999380) is [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate.
What is the SMILES notation for [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate?
The canonical SMILES for [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate is CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H]1COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)[C@@H](CCCCCCC(=O)O1)[C@@H](O)CC(=O)[C@H](/C=C\[C@@H](O)CCCCC)[C@H](O)[C@@H]2O.
What is the InChIKey of [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate?
The InChIKey is MAWFXUAGSBZJKG-HFXXXHFHSA-N. The full InChI is InChI=1S/C50H85N3O18P2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-23-27-45(57)66-34-38-35-67-72(62,63)71-73(64,65)68-36-43-48(60)47(59)39(30-29-37(54)25-21-6-4-2)41(55)33-42(56)40(26-22-19-20-24-28-46(58)69-38)49(70-43)53-32-31-44(51)52-50(53)61/h12-13,29-32,37-40,42-43,47-49,54,56,59-60H,3-11,14-28,33-36H2,1-2H3,(H,62,63)(H,64,65)(H2,51,52,61)/b13-12-,30-29-/t37-,38+,39-,40-,42-,43+,47-,48+,49+/m0/s1.
What are the key properties of [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate?
[(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate has a molecular weight of 1078.18 g/mol, XLogP of 7.59, 24 rotatable bonds, 7 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,9R,18S,19S,22R,23S,24S,26R)-26-(4-amino-2-oxopyrimidin-1-yl)-4,6,19,23,24-pentahydroxy-22-[(Z,3S)-3-hydroxyoct-1-enyl]-4,6,11,21-tetraoxo-3,5,7,10,25-pentaoxa-4λ5,6λ5-diphosphabicyclo[16.6.2]hexacosan-9-yl]methyl (Z)-octadec-9-enoate is sourced from PubChem (CID 156999380), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).